6160 — BeOne Medicines AG Cashflow Statement
0.000.00%
Last trade - 00:00- HK$266.51bn
- HK$237.46bn
- CNY38.22bn
Annual cashflow statement for BeOne Medicines AG, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | CAS | CAS | CAS | CAS | CAS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | -7,254 | -9,674 | -12,843 | -14,880 | -17,694 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -8,285 | -7,800 | -7,793 | -1,259 | 13,713 |
| Capital Expenditures | -2,256 | -2,335 | -4,106 | -3,418 | -1,437 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 5,389 | 4,749 | 4,223 | 1,030 | -10,024 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 3,133 | 2,415 | 117 | -2,389 | -11,461 |
| Financing Cash Flow Items | 22,401 | 146 | 172 | -167 | -507 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 22,867 | -448 | 2,558 | 826 | 652 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 17,674 | -5,764 | -5,073 | -2,841 | 2,947 |